APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aptamer CDMO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Aptamer CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 January 2026192 pages

Choose your research edition.

Industry ResearchAptamer CDMO Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Aptamer CDMO Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Aptamer CDMO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aptamer CDMO Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Aptamer CDMO Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Aptamer CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Aptamer CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Aptamer CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aptamer CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Aptamer CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aptamer CDMO include AMSBIO, Aptagen, Aptamer Group, PORTON, Base Pair, Base Pair Biotechnologies, Cambio, CD Bioparticles and Creative Biolabs, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Aptamer CDMO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Aptamer CDMO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Aptamer CDMO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Aptamer CDMO market size, projected growth trends, production technologies, key applications, and end-use industries.

Aptamer CDMO Segment by Company

AMSBIO

Aptagen

Aptamer Group

PORTON

Base Pair

Base Pair Biotechnologies

Cambio

CD Bioparticles

Creative Biolabs

Eurogentec

Novaptech

Aptamer CDMO Segment by Type

RNA Aptamer CDMO

DNA Aptamer CDMO

Others

Aptamer CDMO Segment by Application

Scientific Research

Medical Treatment

Others

Aptamer CDMO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aptamer CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aptamer CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aptamer CDMO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Aptamer CDMO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Aptamer CDMO industry.

Chapter 3: Detailed analysis of Aptamer CDMO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aptamer CDMOrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aptamer CDMO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of RNA Aptamer CDMO Table 3. Key Players of DNA Aptamer CDMO Table 4. Key Players of Others Table 4. Global Aptamer CDMO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Scientific Research Table 6. Key Players of Medical Treatment Table 7. Key Players of Others Table 8. Global Aptamer CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Aptamer CDMO Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Aptamer CDMO Market Share by Region (2021-2026) Table 11. Global Aptamer CDMO Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Aptamer CDMO Market Share by Region (2027-2032) Table 13. Aptamer CDMO Industry Trends Table 14. Aptamer CDMO Industry Drivers Table 15. Aptamer CDMO Industry Opportunities and Challenges Table 16. Aptamer CDMO Industry Restraints Table 17. Global Aptamer CDMO Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Aptamer CDMO Revenue Market Share by Company (2021-2026) Table 19. Global Aptamer CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Aptamer CDMO Key Company Head Office and Area Served Table 21. Global Aptamer CDMO Company, Product Type & Application Table 22. Global Aptamer CDMO Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Aptamer CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Aptamer CDMO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Aptamer CDMO Revenue Market Share by Type (2021-2026) Table 29. Global Aptamer CDMO Revenue Market Share by Type (2027-2032) Table 30. Global Aptamer CDMO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Aptamer CDMO Revenue Market Share by Application (2021-2026) Table 34. Global Aptamer CDMO Revenue Market Share by Application (2027-2032) Table 35. AMSBIO Company Information Table 36. AMSBIO Business Overview Table 37. AMSBIO Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. AMSBIO Aptamer CDMO Product Portfolio Table 39. AMSBIO Recent Development Table 40. Aptagen Company Information Table 41. Aptagen Business Overview Table 42. Aptagen Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Aptagen Aptamer CDMO Product Portfolio Table 44. Aptagen Recent Development Table 45. Aptamer Group Company Information Table 46. Aptamer Group Business Overview Table 47. Aptamer Group Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Aptamer Group Aptamer CDMO Product Portfolio Table 49. Aptamer Group Recent Development Table 50. PORTON Company Information Table 51. PORTON Business Overview Table 52. PORTON Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. PORTON Aptamer CDMO Product Portfolio Table 54. PORTON Recent Development Table 55. Base Pair Company Information Table 56. Base Pair Business Overview Table 57. Base Pair Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Base Pair Aptamer CDMO Product Portfolio Table 59. Base Pair Recent Development Table 60. Base Pair Biotechnologies Company Information Table 61. Base Pair Biotechnologies Business Overview Table 62. Base Pair Biotechnologies Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Base Pair Biotechnologies Aptamer CDMO Product Portfolio Table 64. Base Pair Biotechnologies Recent Development Table 65. Cambio Company Information Table 66. Cambio Business Overview Table 67. Cambio Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Cambio Aptamer CDMO Product Portfolio Table 69. Cambio Recent Development Table 70. CD Bioparticles Company Information Table 71. CD Bioparticles Business Overview Table 72. CD Bioparticles Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. CD Bioparticles Aptamer CDMO Product Portfolio Table 74. CD Bioparticles Recent Development Table 75. Creative Biolabs Company Information Table 76. Creative Biolabs Business Overview Table 77. Creative Biolabs Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Creative Biolabs Aptamer CDMO Product Portfolio Table 79. Creative Biolabs Recent Development Table 80. Eurogentec Company Information Table 81. Eurogentec Business Overview Table 82. Eurogentec Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Eurogentec Aptamer CDMO Product Portfolio Table 84. Eurogentec Recent Development Table 85. Novaptech Company Information Table 86. Novaptech Business Overview Table 87. Novaptech Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Novaptech Aptamer CDMO Product Portfolio Table 89. Novaptech Recent Development Table 90. North America Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 91. North America Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 92. North America Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 93. North America Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 94. North America Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Aptamer CDMO Market Size by Country (2021-2026) Table 96. North America Aptamer CDMO Market Size by Country (2027-2032) Table 97. Europe Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 98. Europe Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 99. Europe Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 100. Europe Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 101. Europe Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Aptamer CDMO Market Size by Country (2021-2026) Table 103. Europe Aptamer CDMO Market Size by Country (2027-2032) Table 104. China Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 105. China Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 106. China Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 107. China Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 109. Asia Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 110. Asia Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 111. Asia Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 112. Asia Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Asia Aptamer CDMO Market Size by Country (2021-2026) Table 114. Asia Aptamer CDMO Market Size by Country (2027-2032) Table 115. South America, Middle East & Africa Aptamer CDMO Market Size by Type (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Aptamer CDMO Market Size by Type (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Aptamer CDMO Market Size by Application (2021-2026) & (US$ Million) Table 118. South America, Middle East & Africa Aptamer CDMO Market Size by Application (2027-2032) & (US$ Million) Table 119. South America, Middle East & Africa Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. South America, Middle East & Africa Aptamer CDMO Market Size by Country (2021-2026) Table 121. South America, Middle East & Africa Aptamer CDMO Market Size by Country (2027-2032) Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Aptamer CDMO Product Image Figure 2. Global Aptamer CDMO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Aptamer CDMO Market Share by Type: 2025 VS 2032 Figure 4. RNA Aptamer CDMO Image Figure 5. DNA Aptamer CDMO Image Figure 6. Others Image Figure 7. Global Aptamer CDMO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Aptamer CDMO Market Share by Application: 2025 VS 2032 Figure 9. Scientific Research Image Figure 10. Medical Treatment Image Figure 11. Others Image Figure 12. Global Aptamer CDMO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 14. Global Aptamer CDMO Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Aptamer CDMO Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Aptamer CDMO Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Aptamer CDMO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Aptamer CDMO Revenue Market Share by Type (2021-2032) Figure 21. Global Aptamer CDMO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Aptamer CDMO Revenue Market Share by Application (2021-2032) Figure 23. North America Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 24. North America Aptamer CDMO Market Share by Type (2021-2032) Figure 25. North America Aptamer CDMO Market Share by Application (2021-2032) Figure 26. North America Aptamer CDMO Market Share by Country (2021-2032) Figure 27. United States Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 28. Canada Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 30. Europe Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 31. Europe Aptamer CDMO Market Share by Type (2021-2032) Figure 32. Europe Aptamer CDMO Market Share by Application (2021-2032) Figure 33. Europe Aptamer CDMO Market Share by Country (2021-2032) Figure 34. Germany Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 35. France Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 37. Italy Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 38. Russia Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 40. China Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 41. China Aptamer CDMO Market Share by Type (2021-2032) Figure 42. China Aptamer CDMO Market Share by Application (2021-2032) Figure 43. Asia Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 44. Asia Aptamer CDMO Market Share by Type (2021-2032) Figure 45. Asia Aptamer CDMO Market Share by Application (2021-2032) Figure 46. Asia Aptamer CDMO Market Share by Country (2021-2032) Figure 47. Japan Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 51. India Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 52. Australia Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Aptamer CDMO Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Aptamer CDMO Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Aptamer CDMO Market Share by Country (2021-2032) Figure 57. Brazil Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 62. UAE Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 64. Chile Aptamer CDMO Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • RNA Aptamer CDMO
  • DNA Aptamer CDMO
  • Others
Applications
  • Scientific Research
  • Medical Treatment
  • Others
Companies covered
  • AMSBIO
  • Aptagen
  • Aptamer Group
  • PORTON
  • Base Pair
  • Base Pair Biotechnologies
  • Cambio
  • CD Bioparticles
  • Creative Biolabs
  • Eurogentec
  • Novaptech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Aptamer CDMO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 RNA Aptamer CDMO
  5. 1.2.3 DNA Aptamer CDMO
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Aptamer CDMO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Scientific Research
  10. 1.3.3 Medical Treatment
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Aptamer CDMO Growth Trends by Region
  14. 1.5.1 Global Aptamer CDMO Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Aptamer CDMO Market Size by Region (2021-2026)
  16. 1.5.3 Aptamer CDMO Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Aptamer CDMO Market Dynamics
  1. 2.1 Aptamer CDMO Industry Trends
  2. 2.2 Aptamer CDMO Industry Drivers
  3. 2.3 Aptamer CDMO Industry Opportunities and Challenges
  4. 2.4 Aptamer CDMO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Aptamer CDMO Revenue by Company (2021-2026)
  2. 3.2 Global Aptamer CDMO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Aptamer CDMO Key Company Head office and Area Served
  4. 3.4 Global Aptamer CDMO Company, Product Type & Application
  5. 3.5 Global Aptamer CDMO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Aptamer CDMO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Aptamer CDMO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Aptamer CDMO Tier 1, Tier 2, and Tier 3
4 Aptamer CDMO Market by Type
  1. 4.1 Global Aptamer CDMO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Aptamer CDMO Market Size by Type (2021-2032)
  3. 4.3 Global Aptamer CDMO Market Size Share by Type (2021-2032)
5 Aptamer CDMO Market by Application
  1. 5.1 Global Aptamer CDMO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Aptamer CDMO Market Size by Application (2021-2032)
  3. 5.3 Global Aptamer CDMO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AMSBIO
  2. 6.1.1 AMSBIO Company Information
  3. 6.1.2 AMSBIO Business Overview
  4. 6.1.3 AMSBIO Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AMSBIO Aptamer CDMO Product Portfolio
  6. 6.1.5 AMSBIO Recent Developments
  7. 6.2 Aptagen
  8. 6.2.1 Aptagen Company Information
  9. 6.2.2 Aptagen Business Overview
  10. 6.2.3 Aptagen Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Aptagen Aptamer CDMO Product Portfolio
  12. 6.2.5 Aptagen Recent Developments
  13. 6.3 Aptamer Group
  14. 6.3.1 Aptamer Group Company Information
  15. 6.3.2 Aptamer Group Business Overview
  16. 6.3.3 Aptamer Group Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Aptamer Group Aptamer CDMO Product Portfolio
  18. 6.3.5 Aptamer Group Recent Developments
  19. 6.4 PORTON
  20. 6.4.1 PORTON Company Information
  21. 6.4.2 PORTON Business Overview
  22. 6.4.3 PORTON Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 PORTON Aptamer CDMO Product Portfolio
  24. 6.4.5 PORTON Recent Developments
  25. 6.5 Base Pair
  26. 6.5.1 Base Pair Company Information
  27. 6.5.2 Base Pair Business Overview
  28. 6.5.3 Base Pair Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Base Pair Aptamer CDMO Product Portfolio
  30. 6.5.5 Base Pair Recent Developments
  31. 6.6 Base Pair Biotechnologies
  32. 6.6.1 Base Pair Biotechnologies Company Information
  33. 6.6.2 Base Pair Biotechnologies Business Overview
  34. 6.6.3 Base Pair Biotechnologies Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Base Pair Biotechnologies Aptamer CDMO Product Portfolio
  36. 6.6.5 Base Pair Biotechnologies Recent Developments
  37. 6.7 Cambio
  38. 6.7.1 Cambio Company Information
  39. 6.7.2 Cambio Business Overview
  40. 6.7.3 Cambio Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Cambio Aptamer CDMO Product Portfolio
  42. 6.7.5 Cambio Recent Developments
  43. 6.8 CD Bioparticles
  44. 6.8.1 CD Bioparticles Company Information
  45. 6.8.2 CD Bioparticles Business Overview
  46. 6.8.3 CD Bioparticles Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 CD Bioparticles Aptamer CDMO Product Portfolio
  48. 6.8.5 CD Bioparticles Recent Developments
  49. 6.9 Creative Biolabs
  50. 6.9.1 Creative Biolabs Company Information
  51. 6.9.2 Creative Biolabs Business Overview
  52. 6.9.3 Creative Biolabs Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Creative Biolabs Aptamer CDMO Product Portfolio
  54. 6.9.5 Creative Biolabs Recent Developments
  55. 6.10 Eurogentec
  56. 6.10.1 Eurogentec Company Information
  57. 6.10.2 Eurogentec Business Overview
  58. 6.10.3 Eurogentec Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eurogentec Aptamer CDMO Product Portfolio
  60. 6.10.5 Eurogentec Recent Developments
  61. 6.11 Novaptech
  62. 6.11.1 Novaptech Company Information
  63. 6.11.2 Novaptech Business Overview
  64. 6.11.3 Novaptech Aptamer CDMO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Novaptech Aptamer CDMO Product Portfolio
  66. 6.11.5 Novaptech Recent Developments
7 North America
  1. 7.1 North America Aptamer CDMO Market Size (2021-2032)
  2. 7.2 North America Aptamer CDMO Market Size by Type
  3. 7.2.1 North America Aptamer CDMO Market Size by Type (2021-2026)
  4. 7.2.2 North America Aptamer CDMO Market Size by Type (2027-2032)
  5. 7.2.3 North America Aptamer CDMO Market Share by Type (2021-2032)
  6. 7.3 North America Aptamer CDMO Market Size by Application
  7. 7.3.1 North America Aptamer CDMO Market Size by Application (2021-2026)
  8. 7.3.2 North America Aptamer CDMO Market Size by Application (2027-2032)
  9. 7.3.3 North America Aptamer CDMO Market Share by Application (2021-2032)
  10. 7.4 North America Aptamer CDMO Market Size by Country
  11. 7.4.1 North America Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Aptamer CDMO Market Size by Country (2021-2026)
  13. 7.4.3 North America Aptamer CDMO Market Size by Country (2027-2032)
  14. 7.4.4 North America Aptamer CDMO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Aptamer CDMO Market Size (2021-2032)
  2. 8.2 Europe Aptamer CDMO Market Size by Type
  3. 8.2.1 Europe Aptamer CDMO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Aptamer CDMO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Aptamer CDMO Market Share by Type (2021-2032)
  6. 8.3 Europe Aptamer CDMO Market Size by Application
  7. 8.3.1 Europe Aptamer CDMO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Aptamer CDMO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Aptamer CDMO Market Share by Application (2021-2032)
  10. 8.4 Europe Aptamer CDMO Market Size by Country
  11. 8.4.1 Europe Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Aptamer CDMO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Aptamer CDMO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Aptamer CDMO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Aptamer CDMO Market Size (2021-2032)
  2. 9.2 China Aptamer CDMO Market Size by Type
  3. 9.2.1 China Aptamer CDMO Market Size by Type (2021-2026)
  4. 9.2.2 China Aptamer CDMO Market Size by Type (2027-2032)
  5. 9.2.3 China Aptamer CDMO Market Share by Type (2021-2032)
  6. 9.3 China Aptamer CDMO Market Size by Application
  7. 9.3.1 China Aptamer CDMO Market Size by Application (2021-2026)
  8. 9.3.2 China Aptamer CDMO Market Size by Application (2027-2032)
  9. 9.3.3 China Aptamer CDMO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Aptamer CDMO Market Size (2021-2032)
  2. 10.2 Asia Aptamer CDMO Market Size by Type
  3. 10.2.1 Asia Aptamer CDMO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Aptamer CDMO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Aptamer CDMO Market Share by Type (2021-2032)
  6. 10.3 Asia Aptamer CDMO Market Size by Application
  7. 10.3.1 Asia Aptamer CDMO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Aptamer CDMO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Aptamer CDMO Market Share by Application (2021-2032)
  10. 10.4 Asia Aptamer CDMO Market Size by Country
  11. 10.4.1 Asia Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Aptamer CDMO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Aptamer CDMO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Aptamer CDMO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Aptamer CDMO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Aptamer CDMO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Aptamer CDMO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Aptamer CDMO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Aptamer CDMO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Aptamer CDMO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Aptamer CDMO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Aptamer CDMO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Aptamer CDMO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Aptamer CDMO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Aptamer CDMO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Aptamer CDMO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Aptamer CDMO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Aptamer CDMO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst